Icon common questions
PERSONALIZE YOUR WEBSITE EXPERIENCE

Based on your answer below, content on the site will be optimized to show you the most relevant information first.

Which colorectal cancer (CRC) screening option do you prescribe most often to your average-risk patients?

Your most prescribed CRC screening option:
Change Answer

COLOGUARD ADHERENCE

Observed adherence nearly doubles with the Cologuard® test1,2

Patient adherence rates for screening with the Cologuard test and colonoscopy were demonstrated in 2 separate studies1,2:
71%

Adherence

Over 1.5 million of ~2.1 million patients were adherent to the Cologuard test within 1 year based on a retrospective cohort study1

38%

Adherence

~900 of 2400 patients were adherent to screening colonoscopy within 3 years according to a separate clinical study2

Provider has been compensated for sharing her expertise and consulting for Exact Sciences.

Average-risk patients preferred the Cologuard test over colonoscopy in a discrete choice experiment study.5*

From 2018-2021, the Cologuard test contributed 77% to increases in CRC screening adherence.6†

How Can Cologuard Plus™ Screening Meet Today’s Changing Needs?

Hear an expert panel discuss how Cologuard screening can support adherence and why it’s particularly relevant to younger patient populations.

All panelists are paid speakers, presenting on behalf of Exact Sciences. Views, opinions, and information provided during this presentation are based on the speakers’ own clinical practice and experience and are not clinical, diagnostic, or treatment advice for any particular event. Exact Sciences does not recommend or endorse any particular course of treatment or medical choice.

Cologuard box.

Better outcomes with the Cologuard test

View the impact of a positive Cologuard result on follow-up colonoscopy adherence and quality.

Explore Results

After a positive Cologuard result, 77% of patients adhered to a follow-up colonoscopy within 1 year.7‡

Cologuard adherence is supported by its patient navigation program8

According to a study, outreach programs, such as the patient navigation program, improved screening adherence and may help reduce patient burden and CRC mortality rates.8§

Belinda Khou, PA, holding a Cologuard Plus™ test kit box, standing next to Dr James Schultz, MD.
The Cologuard patient navigation program provides encouragement for patients throughout the screening process.
Learn More

Belinda Khou has been compensated for sharing her expertise and consulting for Exact Sciences.

Repeat screening adherence

Discover the impact of the Cologuard test on repeat screening adherence

Learn More
  • *Individuals at average risk for CRC aged 45 to 75 (n=1249) preferred mt-sDNA (38.3%) over colonoscopy (32.5%; P<0.001).5
  • †Based on National Health Interview Survey data on CRC screening rates in 85,571 adults 50-75 years from 2005-2021. Starting in 2018, the survey began including mt-sDNA testing as a screening option. From then until the end of the study period, mt-sDNA testing had the largest increase in utilization and contributed the most to overall screening rates.6
  • ‡Based on a retrospective cohort analysis of 362,646 patients aged 45-75 who received a positive result between January 1, 2017 and June 30, 2022, with the first result serving as the index date.7
  • §Based on a study in a real-world setting that evaluated the impact of different digital outreach channels on patient adherence to CRC screening with a multi-target stool DNA (mt-sDNA) test among 2,425,308 patients aged 50-64 years.8

CRC=colorectal cancer; mt-sDNA=multitarget stool DNA.